Hepatitis B screening and vaccination outreach: triple panel pages, adult vaccine wording, result calls, recall texts and coverage

Hepatitis B outreach asks adults who feel well to take a blood test, and to finish a vaccine series that runs over weeks or months. The program may be a primary care office that adds the test to its recall list, a community health center that serves people born abroad, a liver clinic that takes referrals, a dialysis unit, a travel medicine clinic, a pharmacy that gives adult vaccines, or a health fair that offers screening. This guide covers how to build a screening page on the federal recommendations when CDC and the USPSTF say different things, how to explain triple panel results without overstating them, how to word adult vaccine pages in the words CDC uses, how to word outreach texts and result calls, and how free tests, coverage and partners meet the federal rules.

Nine related topics have their own guides and are not repeated here. Hepatitis C testing is covered in our guide to hepatitis C testing and treatment outreach, liver specialists in our guide to hepatology practice marketing, and HIV testing in our guide to HIV testing and care outreach. Travel vaccines are covered in our guide to travel medicine clinic marketing, seasonal vaccine clinics in our guide to flu shot clinic marketing, and childhood vaccines in our guide to Vaccines for Children provider marketing. Dialysis units are covered in our guide to dialysis center marketing, pop-up screening in our guide to health fair and screening event marketing, and pharmacy services in our guide to pharmacist test and treat marketing. Testing adults at increased risk for TB is covered in tuberculosis testing outreach.

What the federal sources say

The US Preventive Services Task Force (USPSTF), the CDC, MedlinePlus from the National Library of Medicine and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) publish the federal positions on hepatitis B screening, vaccination and care. The points that shape an outreach program’s marketing:

• The CDC page Clinical Testing and Diagnosis for Hepatitis B (updated August 14, 2026, read through an archived copy) says to screen all adults aged 18 and older for hepatitis B at least once in their lifetime using a triple panel test, and that anyone who requests hepatitis B testing should receive it regardless of disclosure of risk. It says CDC published these adult screening recommendations in 2023, and that they were designed as a simpler and less stigmatizing approach than the earlier risk-based screening.
• The same CDC page recommends screening during each pregnancy, preferably in the first trimester, and periodic testing, at any age, for susceptible people whose risk for exposure continues. It names the three tests in the triple panel and says prior guidance recommended a single test.
• The USPSTF final recommendation Hepatitis B Virus Infection in Adolescents and Adults: Screening (December 15, 2020) recommends screening adolescents and adults at increased risk for infection, a grade B recommendation. Its separate recommendation Hepatitis B Virus Infection in Pregnant Women: Screening (July 23, 2019) recommends screening at the first prenatal visit, a grade A recommendation.
• The CDC page Hepatitis B Vaccine (September 18, 2025, read through an archived copy) lists adults aged 19 to 59, and adults aged 60 and older with risk factors, among the groups CDC recommends the vaccine for. It says the vaccine is a series of two or three shots depending on the vaccine brand, that a person needs all of the shots to be fully protected, and that hepatitis B vaccine is safe and effective. The CDC adult immunization schedule notes (2025 schedule, addendum updated July 2, 2025, read through an archived copy) add that adults aged 60 or older without known risk factors may receive a hepatitis B vaccine series.
• The CDC page Hepatitis B Basics (updated August 29, 2025, read through an archived copy) says a person can have hepatitis B without any symptoms and can still spread the virus without symptoms. The CDC page Treatment of Hepatitis B (January 12, 2024, read through an archived copy) says there are medicines approved to treat chronic hepatitis B, that not every person with chronic hepatitis B needs them, and that these medicines do not lead to a cure. It also says people with hepatitis B can live a normal and healthy life.

Because the CDC treatment page is more than two years old and agency statements that a treatment does not cure a condition can change, we checked the current FDA drug labels for chronic hepatitis B, the newest dated July 2026. Each describes treatment of chronic hepatitis B virus infection, and none describes a cure. The USPSTF adolescent and adult recommendation is almost six years old and remains risk based, while the newer CDC recommendation covers all adults. Name the source next to each recommendation, and check the USPSTF site for an update at each review.

Two points shape the marketing. First, CDC now recommends a one-time test for every adult, so an outreach message does not need to ask anyone to admit to a risk: it can say CDC recommends that adults aged 18 and older get tested for hepatitis B at least once, and that anyone who asks for the test can have it. Second, the test and the vaccine work together. A triple panel result tells the person whether they have the infection, are protected, or could still be infected and should be offered the vaccine, so the page has to explain each next step rather than stop at “get tested”.

This guide covers adult screening and adult vaccination. The CDC vaccine page lists ACIP presentation materials from September 18, 2025 on the infant birth dose, and infant and childhood recommendations belong with the current CDC child schedule and our guide to Vaccines for Children provider marketing; a pediatric practice should check the current CDC schedule before it writes about them.

Screening pages and claims that need rewriting

Google’s search suggestions, which we checked on October 30, 2026, offer “hepatitis b test results”, “hepatitis b testing near me”, “hepatitis b test price”, “hepatitis b test for immunity”, “hepatitis b test non reactive means” and “hepatitis b test reactive means” to a person who types “hepatitis b test”, “hepatitis b vaccine schedule for adults”, “hepatitis b vaccine side effects” and “hepatitis b vaccine price” after “hepatitis b vaccine”, “hepatitis b vaccine for adults over 60” and “hepatitis b vaccine for adults near me” after “hepatitis b vaccine for adults”, and “free hepatitis b vaccine” and “free hepatitis b testing near me” after “free hepatitis b”. A screening page can answer each of those honestly: who the test is for, what each result means and what happens next, whether a person is protected, how the vaccine series works for their age, and what the test and the vaccine cost and who pays.

A page that holds up says that CDC recommends a hepatitis B test for every adult at least once, that the test is a blood draw, how long results take, who calls with them and how, and what the next step is for each result. Leave the risk factor list for the clinician conversation or link the CDC page rather than making it the headline, and do not write a headline that singles out any country of birth, ethnic group, sexual orientation or drug use. Where a program serves communities born in regions where hepatitis B is more frequent, reach them through language, place and partners, and keep the headline about the CDC recommendation for all adults.

Phrases that need rewriting:

• “One test tells you if you are safe.” A triple panel result can show infection, protection, a past infection or no protection, and CDC lists a different next step for each. Explain the result types and say a clinician will explain the person’s own result.
• “Hepatitis B is curable with our treatment.” CDC says the medicines approved for chronic hepatitis B do not lead to a cure, and current FDA labels describe treatment, not a cure. Remove it, and say that chronic hepatitis B can be monitored and treated.
• “No symptoms means no hepatitis B.” CDC says a person can have hepatitis B and spread it without symptoms. Say that a blood test is the way to know.
• “Only immigrants need this test.” CDC recommends a test for all adults at least once. Remove it.
• “One shot and you are protected for life.” CDC says the vaccine is a series and a person needs all of the shots to be fully protected. State the series for each age group and say the clinic will remind people when the next dose is due.
• “Our clinic has screened 2,000 people and found 50 cases.” Outcome numbers with no source. Remove them unless they are drawn from the program’s own documented and reviewed records, with their date and limits stated.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. Quoting CDC as written, with the source named, stays inside that standard; turning a federal statement into a promise to the reader does not.

Urgent signs and 911 on every page and in every tool

Two messages belong above the booking button. The MedlinePlus page Hepatitis B (last updated October 25, 2023) says that after contact with the virus, a person may be given a dose of the vaccine, and in some cases another medicine, as soon as possible, and that it is best to get them within 24 hours. The CDC Hepatitis B Basics page lists yellow skin or eyes, dark urine and stomach pain among the symptoms of hepatitis B. Put plain lines on the page and on event flyers: if you think you were exposed to hepatitis B in the last day, for example through a needle or a partner who has hepatitis B, call [phone] today and do not wait for a screening appointment. If you have yellow skin or eyes, call us today. Call 911 for any medical emergency. Ask the program’s clinicians to review each line before it goes live.

The same wording belongs in voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools, and on the card handed out at a screening event. A tool should hand any message about a recent exposure or new yellow skin to a clinician or the on-call line at once, send any message about an emergency to the 911 line and alert staff, pass questions about results to a clinician, and never explain a test result itself. Our guides to the AI chatbot on a practice website and answering service versus AI receptionist cover how tools hand off these messages.

Explaining triple panel results without a diagnosis

The CDC testing page explains that the triple panel combines a test for the virus’s surface protein, a test for the antibody that shows protection, and a test for the antibody that shows a past or current infection. CDC’s result table pairs each pattern with an action: link people with an acute or chronic infection to hepatitis B care, counsel people with a resolved infection about the risk of the virus becoming active again, and offer the vaccine to people who are not protected.

A results page or a results text can set expectations without explaining anyone’s own result. Keep these points:

• Describe the possible outcomes in plain words: you have the infection and we will connect you with care; you are protected; you had the infection in the past and we will talk about what that means for you; or you are not protected and we will offer the vaccine.
• Say that a clinician explains each person’s own result, and how and when they call. Never post or text the result itself.
• For a positive result, name the next step the program has arranged, such as a visit with the program’s own clinician or a referral to a liver specialist, as CDC recommends medical evaluation by a primary care clinician or a specialist.
• Do not write that a person who had hepatitis B in the past is “cured” or “in the clear”. CDC lists counseling about reactivation for that result.
• Name no medicine and no test brand in marketing copy.

Adult vaccine pages: use the CDC wording

Vaccine pages draw the “hepatitis b vaccine schedule for adults”, “hepatitis b vaccine side effects” and “hepatitis b vaccine for adults over 60” searches. Answer each with the CDC wording and date. For age, say CDC recommends the vaccine for adults aged 19 to 59 and for adults 60 and older with risk factors, and that adults 60 and older without known risk factors may receive it. For the schedule, say the series is two or three shots depending on the vaccine the clinic uses, and give the interval for that vaccine from its CDC schedule entry. For side effects, quote the CDC page, which names soreness at the injection site as the leading side effect, and send other questions to the clinician.

Keep these points on a vaccine page:

• Say the person needs every dose of the series to be fully protected, as CDC says, and tell them how the clinic will remind them when the next dose is due.
• Do not name a vaccine brand in ads or on the page. If a person asks which vaccine the clinic uses, the clinician answers.
• Do not promise lifelong protection. CDC says the vaccine gives long-term protection and that boosters are not needed for healthy people in general; quote it with the date, and say the clinician decides about special groups such as people on dialysis.
• Do not write that the vaccine is required for any job, school or travel unless the program has checked that rule for the reader’s case; requirements are set by employers, schools and states.
• Combined hepatitis A and B vaccines and travel timing belong with our guide to travel medicine clinic marketing.

Supplements offered to people with hepatitis B need the same care. The CDC Hepatitis B Basics page tells people with hepatitis B to check with a doctor before taking any prescription pills, nutritional or herbal supplements, or over-the-counter medications, because these can damage the liver. The FDA Questions and Answers on Dietary Supplements (content current as of August 27, 2026) says FDA does not have the authority to approve dietary supplements before they are marketed. Name no product, make no claim that a supplement cleanses or protects the liver or treats hepatitis B, and follow our guide to selling supplements in a medical practice.

Outreach texts, letters and recall lists

Outreach programs reach people through recall lists: adults with no hepatitis B test on file, people who started the vaccine series and missed a dose, people whose result showed no protection and who were offered the vaccine, and people with a positive result who have not returned for care. Under 45 CFR 164.501, a communication about the practice’s own treatment for an individual, such as a reminder to come in for a recommended test, the next vaccine dose or a follow-up visit, can fall outside the definition of marketing, while a message that promotes a third party’s product or service generally needs a signed authorization under 45 CFR 164.508.

The words in the message matter as much as the rule. A text, a postcard or a voicemail can be seen by someone else in the household. Keep these points:

• Name no condition and no test result in the message text. Write “[Practice name] has a recommended screening for you. Call [phone] or book online.” and give the details only after the person signs in or calls.
• A dose reminder can say “Your next vaccine dose is due. Call [phone] or book online.” without naming the vaccine, if the patient has not agreed to more detail.
• Do not mention hepatitis on an envelope, a postcard or a caller ID name, and do not leave a result on voicemail.
• Send messages in the language the patient chose, use the contact method they chose, and honor opt-out requests in every channel.
• Do not send recall lists, test results or vaccine records to an ad platform to build an audience.

Our guides to text message appointment reminders and the patient recall system cover consent, timing and opt-outs.

Free tests, coverage and costs

Coverage pages draw the “hepatitis b test price”, “hepatitis b vaccine price” and “free hepatitis b vaccine” searches. The Medicare.gov page Hepatitis B virus (HBV) infection screenings, checked on October 30, 2026, says Part B covers screening ordered by a provider for people at high risk, once a year if the risk continues and the person does not get the vaccine, and for pregnant people at the first prenatal visit and at delivery if risk factors are new or continue. The Medicare.gov page Hepatitis B vaccines, checked the same day, says Part B covers the vaccine for people who have never had a complete series, do not know their vaccination history, or have a condition that puts them at medium or high risk. Both pages say the person pays nothing if the provider accepts assignment. Describe Medicare coverage in those terms, note that Medicare’s screening criteria are risk based while the CDC recommendation covers all adults, and say the program checks coverage for each patient’s plan. Medicaid coverage is set state by state; our guides to marketing to Medicare patients and marketing to Medicaid patients cover the wider rules.

Treatment and monitoring costs belong in the clinician and billing conversation, not in an ad. Do not write “free hepatitis B care” unless the program has confirmed it for each person it reaches. Cash prices for the test or the vaccine follow our guides to advertising cash prices and good faith estimates for self-pay patients.

A “free” test, a free vaccine dose, a gift card for finishing the series or a meal at a screening event follows 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere, and that the terms of the offer should be stated at the outset. Under 42 U.S.C. 1320a-7a(a)(5), civil penalties can apply to a person who offers or transfers remuneration to a Medicare or state health care program beneficiary that the person knows or should know is likely to influence the beneficiary to order or receive items or services from a particular provider, practitioner or supplier. Incentives for testing or for finishing the vaccine series need counsel’s review before they run, and a grant-funded program should also check its grant terms.

Partners, sponsors and referral payments

Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees are also set state by state.

For a hepatitis B screening and vaccination program, keep these points:

• Do not accept free staff, vaccine doses, event funding or marketing help from a vaccine maker, a drug maker, a lab or a pharmacy tied to the tests, vaccines or prescriptions the program orders, without counsel’s review; our guide to Open Payments covers reported payments from manufacturers.
• Give patients a choice of pharmacy and lab, and do not steer prescriptions or samples to one company in exchange for anything of value.
• Do not pay a community group, a place of worship, a venue, an outreach worker or a marketing company per person screened, vaccinated or referred without counsel’s review.
• Referral arrangements with liver specialists, primary care offices and community partners follow our guide to patient and physician referrals.

Privacy, pixels and ads

A visit to a hepatitis B page, a results question or a booking form says something about a person’s health and may hint at their country of birth or how they might have been exposed. Keep form answers, bookings and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place, language settings and search terms, and should not be built from a list of patients or people who were tested.

Tone and patient stories

People who hear about a hepatitis B test may worry about the result and about being blamed for how they could have been exposed. Lead with the CDC recommendation for all adults, explain each step in plain words, say who will call with results and how, and say that people with hepatitis B can get care. CDC writes that people with hepatitis B can live a normal and healthy life; quote it with the source. Avoid photos or wording that suggest who “looks like” a person with hepatitis B, use person-first words such as “people with hepatitis B”, and offer the page and the results call in the languages the program’s patients speak.

A story from a person who was screened, learned their status and is in care is a strong message for outreach. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. Pair the story with the attributed federal statement, say results differ, and get a signed authorization under 45 CFR 164.508 where the program is a covered entity. A story should not say how the person was exposed unless they chose to share it, should not show their face or name unless they asked for it in writing, and should name no medicine; say if the person received anything for taking part, and let them review the final version. Our guides to patient photo consent and testimonials and before and after photos cover the full rules.

Illustration: two screening outreach messages

Illustration: a flyer reads “Born in Asia or Africa? You probably have hepatitis B. Get the liver test that tells you if you are safe, then one shot protects you for life. Already positive? Our treatment clears hepatitis B. Free screening and a free gift card for everyone!” It singles out people by birthplace, guesses at a diagnosis, says one test answers every question, calls the series a single shot, promises lifelong protection, implies a cure that CDC and the FDA labels do not support, and offers a gift card without counsel’s review.

Illustration: a second flyer for the same program reads “CDC recommends that every adult aged 18 and older get tested for hepatitis B at least once. At [Practice name] it is one blood draw, and anyone who asks for the test can have it. We call you with results within [days] and explain what they mean: whether you have the infection, are protected, or should get the vaccine. If you need the vaccine, it is a series of shots, and we remind you when each one is due. If you think you were exposed in the last day, call [phone] today. Call 911 for an emergency. Call [phone] during [days and hours] to book.” It speaks to all adults, explains the result types and the series, and puts the exposure and emergency lines first.

Checklist before a hepatitis B outreach campaign goes live

• Screening copy built on the CDC 2023 adult recommendation and the USPSTF recommendations, with each source named and dated next to its own population, and the USPSTF page checked for an update at each review.
• No headline that singles out a country of birth, an ethnic group, sex between men or drug use; the risk factor list left for the clinician or linked to CDC.
• Triple panel results described by type in plain words, with the next step for each; no result posted, texted or left on voicemail.
• No cure claim; chronic hepatitis B described as monitored and treated, in the words of CDC, with the FDA label check repeated at each review; no medicine named in marketing copy.
• Adult vaccine pages that quote CDC age groups, the series and side effect wording with dates; no brand names; no promise of lifelong protection; reminders for each dose.
• Infant and childhood vaccine claims left out unless checked against the current CDC child schedule.
• The exposure line, the yellow skin line and the 911 line on pages, flyers, event cards, voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools, reviewed by the program’s clinicians.
• Outreach texts, postcards, caller ID names and voicemails name no condition, vaccine or result; messages in the patient’s language; opt-outs honored.
• Medicare coverage of screening and vaccines described as Medicare.gov states it; coverage checked per patient; no “free care” unless confirmed.
• Free tests, free doses, gift cards and event incentives reviewed by counsel under 16 CFR 251.1 and 42 U.S.C. 1320a-7a(a)(5), and against grant terms.
• No free staff, doses or funding from vaccine makers, drug makers, labs or pharmacies tied to orders, and no per-person payments to partners or venues, without counsel’s review.
• Form answers, bookings and test lists stay out of pixels and ad audiences; stories have signed authorizations, name no medicine and say results differ.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including primary care, community health, liver care, travel medicine and pharmacy practices. For a hepatitis B screening and vaccination program, that means a site that builds its screening page on the CDC and USPSTF recommendations as written and dated, explains triple panel results and the vaccine series in plain words, puts the exposure and 911 lines above the booking button, and answers “hepatitis b testing near me” and “hepatitis b vaccine for adults” searches without a promise, plus appointment request pages that keep answers off the web and away from tracking tools. Our front desk tools hand recent exposures and new symptoms to a clinician or the on-call line, emergencies to the 911 line, and questions about results to a clinician, and do not explain test results. We do not decide who needs testing, vaccination or treatment; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• USPSTF: Hepatitis B Virus Infection in Adolescents and Adults: Screening (final recommendation, December 15, 2020)
• USPSTF: Hepatitis B Virus Infection in Pregnant Women: Screening (final recommendation, July 23, 2019)
• CDC: Clinical Testing and Diagnosis for Hepatitis B (updated August 14, 2026)
• CDC: Hepatitis B Basics (updated August 29, 2025)
• CDC: Hepatitis B Vaccine (September 18, 2025)
• CDC: Treatment of Hepatitis B (January 12, 2024)
• CDC: Adult Immunization Schedule Notes (2025 schedule, addendum updated July 2, 2025)
• MedlinePlus: Hepatitis B (last updated October 25, 2023)
• NIDDK: Hepatitis B (last reviewed December 2024)
• Medicare.gov: Hepatitis B virus (HBV) infection screenings (checked October 30, 2026)
• Medicare.gov: Hepatitis B vaccines (checked October 30, 2026)
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7a: Civil monetary penalties
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing